Dogs and Rats Use Different Brain Peptides to Control Appetite

Pancreatic polypeptides and dynorphin A stimulated feeding in satiated dogs, while NPY and galanin (which work in rats) did not — showing species differ significantly in appetite regulation.

Inui, A et al.·The American journal of physiology·1991·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00196Animal StudyPreliminary Evidence1991RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Pancreatic polypeptides and dynorphin A stimulated feeding in satiated dogs. NPY, galanin, norepinephrine, and GRH did not, despite working in rats.

Key Numbers

How They Did This

Satiated dogs received third ventricle injections of various neuropeptides through chronic cannulas. Food and water intake were measured over specified periods.

Why This Research Matters

Most feeding research is done in rats. This study shows that dogs use different brain peptide systems to control appetite. Since dogs are closer to humans in many ways, this matters for translating appetite research to people.

The Bigger Picture

This species difference challenges the assumption that rat appetite data translates to larger animals and humans. It suggests that weight loss drugs developed in rats may not work as expected in people.

What This Study Doesn't Tell Us

Animal study in dogs. Brain injections do not reflect normal physiology. Small number of peptides tested. The dog may still differ from humans in appetite regulation.

Questions This Raises

  • ?Which appetite regulation system does the human brain use — the rat model or the dog model?
  • ?Should appetite drug development prioritize dog or primate models over rodents?

Trust & Context

Key Stat:
NPY ineffective in dogs NPY, the most potent appetite stimulator in rats, had no feeding effect in dogs — highlighting critical species differences
Evidence Grade:
Preliminary animal study comparing species responses. Important for translational medicine but limited number of peptides tested.
Study Age:
Published in 1991. Species differences in appetite regulation remain a significant challenge in obesity drug development.
Original Title:
Neuropeptide regulation of feeding in dogs.
Published In:
The American journal of physiology, 261(3 Pt 2), R588-94 (1991)
Database ID:
RPEP-00196

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Why are species differences in appetite important?

Billions of dollars are spent developing obesity drugs based on rat brain appetite research. If dogs (and potentially humans) use different peptide systems, many of these drugs may fail in clinical trials — as indeed many have.

Does this mean dynorphin controls human appetite?

It's possible. Dynorphin stimulated feeding in both rats and dogs, making it one of the more conserved appetite signals across species. This supports the known link between the opioid system and food craving in humans.

Read More on RethinkPeptides

Cite This Study

RPEP-00196·https://rethinkpeptides.com/research/RPEP-00196

APA

Inui, A; Okita, M; Nakajima, M; Inoue, T; Sakatani, N; Oya, M; Morioka, H; Okimura, Y; Chihara, K; Baba, S. (1991). Neuropeptide regulation of feeding in dogs.. The American journal of physiology, 261(3 Pt 2), R588-94.

MLA

Inui, A, et al. "Neuropeptide regulation of feeding in dogs.." The American journal of physiology, 1991.

RethinkPeptides

RethinkPeptides Research Database. "Neuropeptide regulation of feeding in dogs." RPEP-00196. Retrieved from https://rethinkpeptides.com/research/inui-1991-neuropeptide-regulation-of-feeding

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.